News


3M Completes Divestment of Drug Delivery Division

May 5, 2020 3M Completes Divestment of Drug Delivery Division

3M has finalized the sale of the majority of its drug delivery business to Altaris Capital Partners LLC.

The US$650 million divestment was announced late last year.  Per the terms of the sale, more than 900 employees of the division, which produces inhalers, micro-needles, and other technologies, will transfer to Altaris, which will operate the segment as a new company known as Kindeva Drug Delivery.

About 3M
With global sales of US$33 billion, 3M is a leading producer of thousands of products ranging from chemicals, filtration systems, and safety and protection equipment to office, graphics, and health care equipment. For more information, visit www.3m.com.